A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast Cancer

Clinical trial NCT04588298 · COMPLETED

Trial details

NCT number: NCT04588298
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-negative Breast Cancer

Start date: 2020-11-02
Primary completion: 2023-06-19
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.